Mythic Therapeutics

0 followers

‌

Mythic Therapeutics’ innovative FateControl technology expands the potential of Antibody Drug Conjugates (ADCs) to destroy cancer and avoid normal cells.

Industries

Headquarters

Employees

Links

Org chart

Sandra Poole

Chief Operating Officer

Nick Mathisen

VP, Head of Information Technology

Teams

Scientific Research Team

9 members

Leadership Team

4 members

Similar companies

Cellares

2 followers

UNC Charlotte

6 followers

Akari Therapeutics

1 follower

Thurgood Marshall College Fund

1 follower

Cargo

1 follower

Apogee Therapeutics

1 follower

Tempus Labs

16 followers

Imvax

1 follower

Adaptive Biotechnologies

12 followers

Elektrofi

1 follower

MedGenome

5 followers

Discover companies